CP and infection: The higher frequency of colistin use observed among patients infected with carbapenemase-producing isolates (both CP CRPA and CP CRE) likely reflects the limited therapeutic options available for these infections during the study period, prior to the widespread availability and reimbursement of novel agents in Korea.